Your browser doesn't support javascript.
loading
PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.
Orozco Morales, M Lizeth; Rinaldi, Catherine A; de Jong, Emma; Lansley, Sally M; Gummer, Joel P A; Olasz, Bence; Nambiar, Shabarinath; Hope, Danika E; Casey, Thomas H; Lee, Y C Gary; Leslie, Connull; Nealon, Gareth; Shackleford, David M; Powell, Andrew K; Grimaldi, Marina; Balaguer, Patrick; Zemek, Rachael M; Bosco, Anthony; Piggott, Matthew J; Vrielink, Alice; Lake, Richard A; Lesterhuis, W Joost.
Affiliation
  • Orozco Morales ML; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Rinaldi CA; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia.
  • de Jong E; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Lansley SM; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia.
  • Gummer JPA; Centre for Microscopy Characterisation and Analysis, Nedlands, WA 6009, Australia.
  • Olasz B; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia.
  • Nambiar S; Institute for Respiratory Health, Nedlands, WA 6009, Australia.
  • Hope DE; School of Science, Department of Science, Edith Cowan University, Joondalup, WA 6027, Australia.
  • Casey TH; UWA Medical School, The University of Western Australia, Crawley, WA 6009, Australia.
  • Lee YCG; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Leslie C; School of Veterinary and Life Science, Murdoch University, Murdoch, WA 6150, Australia.
  • Nealon G; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Shackleford DM; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia.
  • Powell AK; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Grimaldi M; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia.
  • Balaguer P; Institute for Respiratory Health, Nedlands, WA 6009, Australia.
  • Zemek RM; Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, WA 6009, Australia.
  • Bosco A; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia.
  • Piggott MJ; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
  • Vrielink A; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
  • Lake RA; IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier 34090, France.
  • Lesterhuis WJ; IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier 34090, France.
iScience ; 25(1): 103571, 2022 Jan 21.
Article in En | MEDLINE | ID: mdl-34984327
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: IScience Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: IScience Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Estados Unidos